NWAM LLC’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-6,719
| Closed | -$217K | – | 256 |
|
2020
Q2 | $217K | Sell |
6,719
-140
| -2% | -$4.52K | 0.03% | 368 |
|
2020
Q1 | $279 | Sell |
6,859
-200
| -3% | -$8 | 0.01% | 312 |
|
2019
Q4 | $435K | Hold |
7,059
| – | – | 0.08% | 241 |
|
2019
Q3 | $514K | Sell |
7,059
-400
| -5% | -$29.1K | 0.1% | 201 |
|
2019
Q2 | $613K | Sell |
7,459
-440
| -6% | -$36.2K | 0.12% | 167 |
|
2019
Q1 | $557K | Sell |
7,899
-140
| -2% | -$9.87K | 0.12% | 169 |
|
2018
Q4 | $362K | Buy |
8,039
+5
| +0.1% | +$225 | 0.09% | 209 |
|
2018
Q3 | $454K | Sell |
8,034
-575
| -7% | -$32.5K | 0.1% | 202 |
|
2018
Q2 | $575K | Sell |
8,609
-298
| -3% | -$19.9K | 0.14% | 161 |
|
2018
Q1 | $519K | Sell |
8,907
-873
| -9% | -$50.9K | 0.13% | 172 |
|
2017
Q4 | $630K | Sell |
9,780
-2,132
| -18% | -$137K | 0.16% | 141 |
|
2017
Q3 | $625K | Buy |
11,912
+343
| +3% | +$18K | 0.16% | 139 |
|
2017
Q2 | $541K | Sell |
11,569
-825
| -7% | -$38.6K | 0.09% | 145 |
|
2017
Q1 | $614K | Buy |
12,394
+25
| +0.2% | +$1.24K | 0.19% | 123 |
|
2016
Q4 | $750K | Sell |
12,369
-310
| -2% | -$18.8K | 0.25% | 101 |
|
2016
Q3 | $841K | Buy |
12,679
+310
| +3% | +$20.6K | 0.06% | 86 |
|
2016
Q2 | $690K | Buy |
12,369
+840
| +7% | +$46.9K | 0.27% | 92 |
|
2016
Q1 | $388K | Sell |
11,529
-330
| -3% | -$11.1K | 0.15% | 139 |
|
2015
Q4 | $535K | Buy |
+11,859
| New | +$535K | 0.22% | 105 |
|